Loxoprofen
- Generic Name
- Loxoprofen
- Drug Type
- Small Molecule
- Chemical Formula
- C15H18O3
- CAS Number
- 68767-14-6
- Unique Ingredient Identifier
- 3583H0GZAP
Overview
Loxoprofen is a propionic acid derivative non-steroidal anti-inflammatory drug. It is marketed under the trade name Loxonin in Brazil, Mexico and Japan by Sankyo, as Loxomac in India, and as Oxeno in Argentina. A transdermal preparation was approved for use in Japan in January 2006.
Background
Loxoprofen is a propionic acid derivative non-steroidal anti-inflammatory drug. It is marketed under the trade name Loxonin in Brazil, Mexico and Japan by Sankyo, as Loxomac in India, and as Oxeno in Argentina. A transdermal preparation was approved for use in Japan in January 2006.
Indication
Loxoprofen is non-steroidal anti-inflammatory medication (NSAID) indicated for pain and inflammation related to musculoskeletal and joint disorders. In addition to its effects on pain, it is an antipyretic and anti-inflammatory medication.
Associated Conditions
- Musculoskeletal Pain
- Rheumatism
- Soft Tissue Injury
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/07/19 | Phase 1 | Not yet recruiting | |||
2023/09/21 | Phase 2 | Not yet recruiting | |||
2019/01/11 | Phase 4 | Completed | Sun Yat-sen University | ||
2016/07/13 | Phase 3 | Completed | |||
2015/11/26 | Phase 3 | Completed | |||
2015/11/11 | Phase 2 | Completed | |||
2015/06/10 | Phase 2 | Completed | |||
2013/08/14 | Phase 2 | Completed | |||
2013/01/30 | Phase 3 | Completed | |||
2011/12/14 | Phase 2 | UNKNOWN |
FDA Approved Products
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
|---|
No FDA products found
No FDA products found for this drug
EMA Approved Products
Product Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
|---|
No EMA products found
No EMA products found for this drug
HSA Approved Products
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval Number |
|---|
No HSA products found
No HSA products found for this drug
NMPA Approved Products
Product Name | Approval Number | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
|---|---|---|---|---|---|---|---|---|---|
国药准字H20030769 | 片剂 | 乐松 | 60mg | Chemical Drug | Approved | 2024/05/24 | Domestic | ||
国药准字H20123120 | 片剂 | N/A | 60mg(按无水物计)。 | Chemical Drug | Approved | 2021/09/13 | Domestic | ||
国药准字H20052275 | 片剂 | 洛列通 | 60mg（以C₁₅H₁₇NaO₃计） | Chemical Drug | Approved | 2020/08/03 | Domestic | ||
国药准字H20050114 | 片剂 | 赛克同 | 60mg | Chemical Drug | Approved | 2020/05/22 | Domestic | ||
国药准字H20050437 | 片剂 | 洛那 | 60mg(以C15H17NaO3计) | Chemical Drug | Approved | 2020/01/09 | Domestic | ||
国药准字H20203538 | 片剂 | N/A | 60mg(按C15H17NaO3计) | Chemical Drug | Approved | 2020/10/27 | Domestic | ||
国药准字H20030617 | 片剂 | N/A | 60mg(按无水物计) | Chemical Drug | Approved | 2020/08/13 | Domestic | ||
国药准字H20041923 | 片剂 | 安普洛 | 60mg | Chemical Drug | Approved | 2020/06/04 | Domestic | ||
国药准字H20041143 | 片剂(薄膜衣片) | 真侗言 | 60mg（以C₁₅H₁₇NaO₃计） | Chemical Drug | Approved | 2020/02/20 | Domestic | ||
国药准字H20030614 | 片剂 | 若迈 | 60mg(以C15H17NaO3计) | Chemical Drug | Approved | 2020/03/27 | Domestic |
PPB Approved Products
Product Name | Registration Code | Company | Category | Sale Type | Registration Date |
|---|
No PPB products found
No PPB products found for this drug
TGA Approved Products
Product Name | ARTG ID | Sponsor | Status | Registration Date | Ingredient |
|---|
No TGA products found
No TGA products found for this drug